Dashboard
Manage Tickers

AVIRAtea Pharmaceuticals, Inc.

Nasdaq ateapharma.com


$ 3.66 $ -0.05 (-1.35 %)    

Friday, 17-May-2024 15:59:30 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.31 (0.06 %)
TLT $ 91.40 $ -0.22 (-0.24 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 3.65
$ 3.74
$ 0.00 x 0
$ 0.00 x 0
$ 3.64 - $ 3.74
$ 2.77 - $ 5.19
320,357
na
310.49M
$ 0.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 12-10-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

atea-pharmaceuticals-q1-2024-gaap-eps-075-misses-061-estimate
Atea Pharmaceuticals Q1 2024 GAAP EPS $(0....
05/14/2024 20:16:37

Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate o...

atea-pharmaceuticals-completes-patient-enrollment-in-global-phase-3-sunrise-3-trial-evaluating-bemnifosbuvir-for-covid-19-in-high-risk-patients
Atea Pharmaceuticals Completes Patient Enr...
03/27/2024 11:05:03

recap-atea-pharmaceuticals-q4-earnings
Recap: Atea Pharmaceuticals Q4 Earnings
02/28/2024 21:35:31

atea-pharmaceuticals-q4-2023-gaap-eps-047-beats-051-estimate
Atea Pharmaceuticals Q4 2023 GAAP EPS $(0....
02/28/2024 21:31:46

Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of ...

earnings-scheduled-for-february-28-2024
Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

atea-pharmaceuticals-earnings-preview
Atea Pharmaceuticals Earnings Preview
02/27/2024 20:01:59

atea-pharmaceuticals-hepatitis-c-virus-candidate-shows-efficacy
Atea Pharmaceuticals' Hepatitis C Virus Ca...
01/09/2024 18:33:35

Atea Pharmaceuticals Inc (NASDAQ: AVIR) reported initial data from the first 52 patients in the lead-in cohort of its Phase 2 c...

atea-pharmaceuticals-announces-initial-data-from-phase-2-study-for-hepatitis-c-virus-and-significant-enrollment-milestone-for-phase-3-sunrise-3-trial-for-covid-19
Atea Pharmaceuticals Announces Initial Dat...
01/08/2024 21:09:17

A 98% Sustained Virologic Response at Week 4 (SVR4) Post-Treatment Observed in Initial Data From 52 Patients in Lead-In Cohort ...

atea-pharmaceuticals-inc-receives-orphan-designation-status-from-us-fda-for-a-phosphoramidate-oral-prodrug-of-a-unique-6-modified-purine-nucleotide-for-treatment-of-disease-caused-by-dengue-virus
Atea Pharmaceuticals Inc. Receives Orphan ...
12/18/2023 14:49:33

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=976523  

atea-pharmaceuticals-q3-eps-040-beats-048-estimate
Atea Pharmaceuticals Q3 EPS $(0.40) Beats ...
11/08/2023 22:19:01

Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of ...

earnings-scheduled-for-november-8-2023
Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

atea-pharmaceuticalss-earnings-outlook
Atea Pharmaceuticals's Earnings Outlook
11/07/2023 18:01:52

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
10/02/2023 17:00:10

  On Monday, 369 companies set new 52-week lows.

benzingas-top-ratings-upgrades-downgrades-for-august-10-2023
Benzinga's Top Ratings Upgrades, Downgrade...
08/10/2023 15:00:36

jp-morgan-downgrades-atea-pharmaceuticals-to-underweight
JP Morgan Downgrades Atea Pharmaceuticals ...
08/10/2023 09:28:54

JP Morgan analyst Eric Joseph downgrades Atea Pharmaceuticals (NASDAQ:AVIR) from Neutral to Underweight.

atea-pharmaceuticals-q2-eps-034-beats-047-estimate
Atea Pharmaceuticals Q2 EPS $(0.34) Beats ...
08/08/2023 21:39:38

Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of ...

earnings-scheduled-for-august-8-2023
Earnings Scheduled For August 8, 2023
08/08/2023 08:48:24

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share o...

earnings-preview-for-atea-pharmaceuticals
Earnings Preview For Atea Pharmaceuticals
08/07/2023 19:01:01

atea-pharma-dosed-first-patient-in-phase-2-study-for-treatment-of-hepatitis-c-with-bemnifosbuvir-and-ruzasvir-combination
Atea Pharma Dosed First Patient in Phase 2...
06/15/2023 11:04:36

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) ("Atea"), a clinical-stage biopharmaceutical company engaged in the discovery ...

why-nvidia-shares-are-trading-higher-by-over-5-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Nvidia Shares Are Trading Higher By Ov...
05/30/2023 17:27:22

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek S...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION